Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: U.S. Surgical

This article was originally published in The Gray Sheet

Executive Summary

U.S. Surgical: MIBB breast biopsy instrumentation system will be launched in the first quarter of 1998 following 510(k) clearance, the company announces Dec. 11. Formerly called the PERC ABBI ("The Gray Sheet" Sept. 22, I&W-1), the "needle-like" radiolucent system is designed for use with either USSC's ABBI biopsy instrument and a sterotactic table made by Trex Medical's Lorad unit (x-rays), or with USSC's Sonopsy three-dimensional ultrasound system. While the ABBI alone can remove tissue samples ranging from 5 mm to 20 mm in diameter, the MIBB system allows removal of samples "as small as 2 mm in diameter," USSC claims...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009273

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel